BALA CYNWYD, PA / ACCESSWIRE / September 12, 2019 / Brodsky & Smith, LLC is investigating class action lawsuits against the following companies for violations of federal securities laws. There is no cost or financial obligation to you. According to the complaint, defendants made materially false and/or misleading statements and/or failed to disclose that: Throughout the Class Period, the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a “predictable and manageable tolerability profile” and a “very nice safety profile,” and assured investors that it was “well tolerated” by patients.

source https://finance.yahoo.com/news/class-action-lawsuit-brodsky-smith-101000278.html?.tsrc=rss